Related Experiment Videos
[Asymptomatic carotid stenoses. Analysis of randomized studies]
1Service de Chirurgie vasculaire, Hôpital Saint-Michel, Paris.
Journal Des Maladies Vasculaires
|January 1, 1993
Summary
Surgical intervention for asymptomatic carotid artery stenosis shows promise. Recent trials suggest surgery may reduce vascular events compared to aspirin, with low morbidity and mortality rates.
Area of Science:
- Vascular Surgery
- Neurology
- Clinical Trials
Context:
- Asymptomatic carotid artery stenosis (CAS) management remains debated.
- Recent randomized clinical trials (RCTs) influence treatment decisions.
- Surgical versus medical management strategies are under scrutiny.
Purpose:
- To evaluate the efficacy and safety of surgical intervention versus medical management (aspirin) for asymptomatic carotid artery stenosis.
- To analyze outcomes from key RCTs including the Veterans Administration study, Casanova Study, and the French AURC trial.
- To assess the trend towards surgical treatment based on reported outcomes.
Summary:
- Interim Veterans Administration trial results indicated lower vascular events (2.4%) and mortality (1.9%) with surgery versus aspirin (5% neurologic events).
- The Casanova Study found no significant difference in neurologic events or mortality between endarterectomy and medical treatment.
- The French AURC trial demonstrated a significant reduction in neurologic accidents with surgery after 45 months follow-up.
Impact:
- A trend towards surgical intervention for asymptomatic CAS is emerging.
- Advances in anesthesia, like local/regional plexus anesthesia, contribute to low surgical risks (<2% morbidity, minimal mortality).
- Evidence suggests surgery may offer improved outcomes for select patients with asymptomatic carotid artery stenosis.